GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » EV-to-FCF

McKesson Europe AG (HAM:CLS1) EV-to-FCF : 5,707.99 (As of Apr. 30, 2024)


View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, McKesson Europe AG's Enterprise Value is €5,137 Mil. McKesson Europe AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2022 was €1 Mil. Therefore, McKesson Europe AG's EV-to-FCF for today is 5,707.99.

The historical rank and industry rank for McKesson Europe AG's EV-to-FCF or its related term are showing as below:

HAM:CLS1's EV-to-FCF is not ranked *
in the Medical Distribution industry.
Industry Median: 22.77
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-30), McKesson Europe AG's stock price is €24.40. McKesson Europe AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was €-4.290. Therefore, McKesson Europe AG's PE Ratio for today is At Loss.


McKesson Europe AG EV-to-FCF Historical Data

The historical data trend for McKesson Europe AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG EV-to-FCF Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.02 21.75 25.40 21.67 5,376.93

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.02 21.75 25.40 21.67 5,376.93

Competitive Comparison of McKesson Europe AG's EV-to-FCF

For the Medical Distribution subindustry, McKesson Europe AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's EV-to-FCF falls into.



McKesson Europe AG EV-to-FCF Calculation

McKesson Europe AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5137.191/0.9
=5,707.99

McKesson Europe AG's current Enterprise Value is €5,137 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. McKesson Europe AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2022 was €1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (HAM:CLS1) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

McKesson Europe AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=24.40/-4.290
=At Loss

McKesson Europe AG's share price for today is €24.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. McKesson Europe AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was €-4.290.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


McKesson Europe AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (HAM:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines